Join the Atrial Fibrillation group to help and get support from people like you.
Atrial Fibrillation News (Page 3)
Related terms: A-fib, Paroxysmal Atrial Fibrillation, PAF, AFib, AF
A-Fib Risk Drops Soon After Quitting Smoking
FRIDAY, Sept. 13, 2024 – Smokers who make the decision to quit will see almost immediate health benefits, including a quick drop in their risk for atrial fibrillation, new research shows. “The f...
Smoking Cessation Linked to Lower Risk for Atrial Fibrillation
FRIDAY, Sept. 13, 2024 – Smoking cessation is associated with a reduced risk for atrial fibrillation (AF), according to a study published online Sept. 11 in JACC: Clinical Electrophysiology. Justin...
A-Fib May Be 3 Times More Common Than Thought
THURSDAY, Sept. 12, 2024 – The number of Americans with a potentially dangerous heart rhythm condition is three times greater than previously thought, a new study claims. An estimated 5% of the...
Pulmonary Vein Isolation Yields Reduction in A-Fib Burden
THURSDAY, Sept. 5, 2024 – For patients with symptomatic paroxysmal or persistent atrial fibrillation, pulmonary vein isolation results in a significant and clinically important reduction in atrial...
Could Your Cellphone Be Harming Your Heart?
WEDNESDAY, Sept. 4, 2024 – Your cellphone might be harming your heart, a new study warns. People who regularly use a cellphone have a higher risk of heart disease, researchers found in a large-scale...
Wearable Heart Monitor Ups Detection of A-fib by More Than 50%
WEDNESDAY, Sept. 4, 2024 – A wearable heart monitor raises the detection rate of the dangerous irregular heartbeat known as atrial fibrillation (A-fib) by more than 50%, a new study finds....
Lower Potassium Threshold After CABG Safe for A-Fib Prevention
WEDNESDAY, Sept. 4, 2024 – Potassium supplementation at a threshold of
Women Have Lower Risk for Postoperative A-Fib After Cardiac Surgery
FRIDAY, Aug. 23, 2024 – Women have a lower incidence of developing postoperative atrial fibrillation (poAF) after cardiac surgery, but those with poAF have increased mortality risk compared with men...
Work Stress May Help Bring on A-Fib
THURSDAY, Aug. 15, 2024 – Low-paid employees under crushing work stress have a nearly doubled risk of developing a dangerous heart rhythm disorder, a new study finds. White-collar workers with...
Psychosocial Stressors at Work Linked to Increased Risk for A-Fib
WEDNESDAY, Aug. 14, 2024 – Psychosocial stressors at work, defined by job strain and effort-reward imbalance (ERI) at work, are associated with an increased risk for atrial fibrillation (AF),...
Wearables Linked to Higher Specific, Informal Health Care Use in A-Fib
TUESDAY, Aug. 13, 2024 – For patients with atrial fibrillation (AF), wearable devices are associated with higher AF-specific health care use and informal health care resource use, according to a...
FDA Approves Savaysa (edoxaban) to Prevent Embolic Events in Non-Valvular Atrial Fibrillation
January 8, 2015 – The U.S. Food and Drug Administration today approved the anti-clotting drug Savaysa (edoxaban tablets) to reduce the risk of stroke and dangerous blood clots (systemic embolism) in...
Arbor Pharmaceuticals Announces FDA Approval of Sotylize
Atlanta, GA — October 23,2014 – Arbor Pharmaceuticals announced today that the U.S. Food and Drug Administration (FDA) has approved its New Drug Application (NDA) for Sotylize (sotalol h...
FDA Approves Eliquis to Reduce the Risk of Stroke, Blood Clots in Patients with Non-Valvular Atrial Fibrillation
December 28, 2012 – The U.S. Food and Drug Administration today approved the anti-clotting drug Eliquis (apixaban), an oral tablet used to reduce the risk of stroke and dangerous blood clots...
FDA Approves Pradaxa to Prevent Stroke in People With Atrial Fibrillation
SILVER SPRING, Md., Oct. 19 /PRNewswire-USNewswire/ – The U.S. Food and Drug Administration today approved Pradaxa capsules (dabigatran etexilate) for the prevention of stroke and blood clots in...
Further information
Related drug support groups
metoprolol, propranolol, Xarelto, clonidine, carvedilol, diltiazem, digoxin, flecainide, sotalol, rivaroxaban, Coreg